RSS   Newsletter   Contact   Advertise with us
Post Online Media

Milan Zdravkovic joins Sobi as SVP, head of R&D

Milan ZdravkovicSwedish Orphan Biovitrum AB (Sobi), a specialty healthcare company, announced that Milan Zdravkovic has been appointed SVP, head of research & development, effective November 1, 2016.
Article continues below

READ MORE HKEx Liz Milan named head of Asia commodities

Mr. Zdravkovic joins Sobi from Novo Nordisk where he has had an 18 year tenure in the Research and Development organisation responsible for therapeutic areas including diabetes, growth hormone deficiency, obesity and immunology.

Mr. Zdravkovic’s experience spans early stage development to post-approval life-cycle management in these areas.

His most recent role was as Corporate Vice President, Obesity.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy